According to Lumos Pharma's latest financial reports the company's current EPS (TTM) is -โน405.77. In 2022 the company made an earnings per share (EPS) of -โน398.02 a decrease over its 2021 EPS that were of -โน311.01.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน386.75 | -2.83% |
2022 | -โน398.02 | 27.98% |
2021 | -โน311.01 | 305.62% |
2020 | -โน76.67 | -90.26% |
2019 | -โน787.42 | -29.48% |
2018 | -โน1,117 | -38.72% |
2017 | -โน1,822 | -20.07% |
2016 | -โน2,280 | 111.51% |
2015 | -โน1,078 | -137.77% |
2014 | โน2,853 | -396.77% |
2013 | -โน961.45 | 10.71% |
2012 | -โน868.40 | 6.4% |
2011 | -โน816.14 |